Jele Chemists Pty Ltd v Australian Community Pharmacy Authority

Link copied
Case Copied 47 min read

FEDERAL COURT OF AUSTRALIA

Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2023] FCA 1652  

File number(s): QUD 293 of 2022
Judgment of: MEAGHER J
Date of judgment: 21 December 2023
Catchwords:

ADMINISTRATIVE LAW – Judicial review – Recommendation to the Secretary of the Department for Health and Aged Care by the Australian Community Pharmacy Authority (Authority) that approval be granted to supply pharmaceutical benefits from a particular premises – Where approval is granted to supply pharmaceutical benefits from a particular premises – Whether Authority had jurisdiction to make recommendation – Whether Authority had to have regard to with local government and State and Territory planning laws – Consideration of the definition of proposed premises – Application dismissed

PRACTICE AND PROCEDURE – Notice of Objection to Competency – Whether applicant has standing – Whether applicant has interests exceeding those of ordinary members of the public – Where purported standing has changed from when application was filed – Whether economic interest and close proximity of premises satisfies standing – Notice of objection to competency dismissed

Legislation:

Acts Interpretation Act 1901 (Cth) ss 13,15AA, 15AB

Administrative Decisions (Judicial Review) Act 1977 (Cth) s 5

Legislation Act 2003 (Cth) ss 13(1), 13(1)(c)

National Health Act 1953 (Cth) ss 90, 90(A), 90(3A), 99L

Planning Act 2016 (Qld) ss 49(1), 71, 72, 229(3)(g) National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth) rr 5, 10(2), 10(3), 11(a), Sch 1, Pt 2, Item 130

Cases cited:

(Argos Pty Ltd v Corbell, Minister for the Environment and Sustainable Development (2014) 254 CLR 394

Assarapin v Australian Community Pharmacy Authority (2016) 239 FCR 161

Australian Broadcasting Corporation v Lenah Games Meats (2001) 208 CLR 199

CIC Insurance Ltd v Bankstown Football Club Ltd (1997) 187 CLR 384

Drake and Minister for Immigration and Ethnic Affairs (No 2) (1979) 2 ALD 634

Hallgath v Australian Community Pharmacy Authority [2011] FCA 1062

Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2022] FCA 1445

Project Blue Sky Inc v Australian Broadcasting Authority (1998) 194 CLR 355

R v A2 (2019) 269 CLR 507

R v Australian Broadcasting Tribunal; Ex parte Hardiman (1980) 144 CLR 13

Secretary, Dept of Housing, Local Government and Community Services v Kaderbhai (1994) 51 FCR 416

Stambe v Minister for Health (2019) 270 FCR 173

SZTAL v Minister for Immigration and Border Protection (2017) 262 CLR 362

Terry White Chemists Australia Fair v Secretary to the Department of Health and Ageing (2009) 178 FCR 161

Tooheys Ltd v Minister for Business and Consumer Affairs (1981) 36 ALR 64

Walkerden v Wodonga Pharmacy Pty Ltd [2015] FCA 273

Watson v Australian Community Pharmacy Authority (2012) 206 FCR 365

Division: General Division
Registry: Queensland
National Practice Area: Administrative and Constitutional Law and Human Rights
Number of paragraphs: 106
Date of hearing: 7 June 2023
Counsel for the Applicant: Mr C Gunson SC and Ms R Howe
Counsel for the First and Third Respondents: Ms K Slack
Counsel for the Second Respondent: Mr T Flaherty
Solicitor…
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Jele Chemists Pty Ltd v Australian Community Pharmacy Author... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] FCA 1652
Decision Date

CaseChat Overview and Summary

The case before the court involved Jele Chemists Pty Ltd as the applicant and the Australian Community Pharmacy Authority as the respondent. The primary dispute centred on the recommendation made by the Authority to the Secretary of the Department for Health and Aged Care regarding the approval of pharmaceutical benefits supply from specific premises. The applicant contested the Authority's jurisdiction and the necessity for the Authority to consider local government and State and Territory planning laws in making its recommendation. The court was tasked with determining whether the Authority had the authority to make such a recommendation and whether it was required to take into account planning laws in doing so.

The central legal issues before the court were whether the Authority had the jurisdiction to recommend the approval of pharmaceutical benefits supply from the premises in question and whether the Authority was obligated to consider local government and State and Territory planning laws in making its recommendation. The applicant argued that the Authority did not have the jurisdiction to recommend approval without considering planning laws and that the Authority's decision-making process was flawed as a result.

The court dismissed the applicant's claims. It held that the Authority did have the jurisdiction to make the recommendation and that there was no obligation for the Authority to consider local government and State and Territory planning laws. The court found that the definition of "premises" was not ambiguous and that the Authority's decision did not constitute an error of law. Furthermore, the court dismissed the Notice of Objection to Competency, determining that the applicant did not have standing to object to the Authority's competency, as the applicant's interests did not exceed those of ordinary members of the public.

The court ordered the dismissal of the Notice of Objection to Competency and the Further Amended Originating Application. The parties were directed to confer regarding costs by a specified date and to file written submissions on the costs, with an opportunity for reply submissions. The court reserved the right to determine the costs on the papers unless either party sought to be heard orally.

Orders

Orders of the court

1. The Notice of Objection to Competency filed on 3 April 2023 be dismissed.

2. The Further Amended Originating Application filed on 29 March 2023 be dismissed.

3. By 4:00 pm AEST on 25 January 2024, the parties are to confer regarding costs.

4. By 4:00 pm AEST on 2 February 2024, the parties are to file and serve either:

(a) a joint memorandum; or

(b) separate written submissions;

on the topic of costs, not exceeding three pages with 12-point font and 1.5 line spacing, together with proposed orders.

5. In the event that the parties file written submissions, then by 4:00 pm AEST on 9 February 2024, each party may file written submissions in reply, not exceeding two pages with 12-point font and 1.5 line spacing.

6. The question of costs is to be determined on the papers thereafter, unless either party seek to be heard orally.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Section 72 of the Planning Act provides when development may start:(1) Development under a development approval may start when—(a)all development permits for the development have started to have effect; and(b)all development conditions of the permits that are required to be complied with before development starts have been complied with.(1)However, if an appeal is started in relation to a development approval, other than an appeal about a change application or extension application, development must not start until—(a) the appeal ends; or(b) the tribunal or court hearing the appeal allows all or part of the development to start, because the tribunal or court considers the outcome of the appeal would not be affected.BACKGROUND On 24 August 2021, a development application was lodged with the Toowoomba Regional Council for a Material Change of Use – Health Care Services (Medical Centre) and Shop (Pharmacy) in connection with the Glenvale Premises (Development Application). In November 2021, submissions were made to the Council as part of the public notification phase of the Development Application. On 1 April 2022, the Council issued a Decision Notice approving the Development Application, and on 14 April 2022 it issued letters to those who made submissions to it during the public notification phase advising of the decision and providing details of appeal rights. On 12 April 2022, the applicant lodged an application with the Minister for Health and Aged Care to exercise his power pursuant to s 90A(2) of the Act to approve the supply of pharmaceutical benefits (Applicant’s Application) at the property located at Shop 2, Glenvale Shopping Centre, Toowoomba Queensland 4350 (Applicant’s Premises). The background to this application is a preceding application made by the applicant on 16 December 2021 pursuant to Sch 1, Pt 2, Item 30 of the Rules for approval to supply pharmaceutical benefits from the Applicant’s Premises, which was rejected on 17 February 2022 as the Authority was not satisfied that the Applicant’s Premises were located at least 1.5 km, in a straight line, from the nearest approved premises. On 20 April 2022, Glenvale Pharmacy lodged an application pursuant to Sch 1, Pt 2, Item 130 of the Rules for approval to supply pharmaceutical benefits from the Glenvale Premises (Glenvale Pharmacy’s Application). The Glenvale Premises are located within 300 metres in a straight line from the Applicant’s Premises. On 28 April 2022, solicitors for the applicant sent an email to the “Ministerial Discretion Team” of the Department of Health asking to be notified of any application to establish a new pharmacy and/or to relocate an existing pharmacy within 5 kilometres of the Glenvale Premises for the purposes of making comments on such applications as an interested party. On 2 May 2022, the applicant was notified of Glenvale Pharmacy’s Application. On 10 May 2022, an appeal was lodged by Stokes Lawyers, who acted for the applicant some time prior to these proceedings, with the Planning and Environment Court against the Council's approval of the Development Application. Final orders were made on 9 June 2022 granting leave to discontinue the appeal.

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ground 1A does not succeed. CONCLUSION The Notice of Objection to Competency and the Further Amended Originating Application are dismissed. Orders will be made for the provision of submissions with respect to the question of costs.

Ratio Decidendi

Legal Principle Established